Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
111 pending office actions • 61 clients • 107 examiners • 62 art units • 0 of 111 (0%) have an AI response strategy ready
BROWN RUDNICK LLP demonstrates extensive experience in Biotechnology & Pharmaceuticals with 4189 career applications. The firm is currently managing 85 pending office actions, reflecting a high level of current activity. Its resolved allowance rate is 83.26 percent, showing a high success rate in a complex technology area.
Prosecution requires an average of 3.89 office actions per allowance, which is a significant investment in time and resources per granted patent. The 4189 career applications establish the firm as a major player in biotechnology, and the 3.89 average office actions per allowance highlights the rigorous nature of examination in this sector.
Based on the USPTO statutory response window for each pending office action. 44 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 44 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 4 (4%) |
| §101 + other | 11 (10%) |
| §103 only | 27 (24%) |
| §102 only | 7 (6%) |
| §112 only | 10 (9%) |
| Double-patenting only | 2 (2%) |
| Double-patenting + other | 9 (8%) |
| Multi-statute (no §101) | 40 (36%) |
| No statute on record | 1 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CELESTINE, NYROBI I | 3 | 81.4% | +23.1% |
| GIULIANI, THOMAS ANTHONY | 2 | 76.5% | +37.3% |
| SHAFQAT, AMY JEANETTE | 2 | 52.0% | +55.3% |
| EL-HAGE HASSAN, ABDALLAH A | 1 | 42.9% | +40.4% |
| MIANO, JOSEPH PAUL | 1 | 35.7% | +63.4% |
| PARSLEY, DAVID J | 1 | 54.0% | +28.8% |
| UBER, NATHAN C | 1 | 3.4% | +5.5% |
| NGUYEN, SANG H | 1 | 88.7% | +11.7% |
| SELLS, JAMES D | 1 | 81.5% | +11.9% |
| COLLARD JR, DWANE EDWARD | 1 | 0.0% | +0.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18763063 | SYSTEMS AND METHODS FOR TISSUE ANALYSIS AND VISUALIZATION | CELESTINE, NYROBI I | 3d overdue |
| 19075578 | SYSTEMS AND METHODS FOR PRINTING AND APPLYING LABELS | SELLS, JAMES D | — |
| 18763044 | SYSTEMS AND METHODS FOR ROTATIONAL ULTRASOUND FOCUSING | CELESTINE, NYROBI I | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18104364 | Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase | ANDERSON, REBECCA L | 132d overdue |
| 18931823 | SYSTEMS AND METHODS FOR PROVIDING PERSONALIZED HEALTH RISK ASSESSMENTS AND RECOMMENDATIONS | HANKS, BENJAMIN L | 103d overdue |
| 18667133 | BIN OUTPUT EXPANDER DEVICES, SYSTEMS, AND METHODS | DEVINE, MOLLY K | 86d overdue |
| 17614826 | METHODS OF ALTERING CARDIAC REMODELING USING COMPOUNDS THAT PROMOTE GLUCOSE OXIDATION | NESTOR, DONNA MICHELLE | 74d overdue |
| 18382772 | BENDING THE PROBES OF DEPTH GAUGES | COLEY, ZADE JAMES | 56d overdue |
| 18157616 | T CELL RECEPTOR (TCR) COMPOSITIONS AND METHODS FOR OPTIMIZING ANTIGEN REACTIVE T-CELLS | VIJAYARAGHAVAN, JAGAMYA NMN | 49d overdue |
| 18427093 | PROSTATE MEASUREMENT SYSTEM | SHAH, JAY B | 45d overdue |
| 16757655 | METHOD OF TAGGING NUCLEIC ACID SEQUENCES, COMPOSITION AND USE THEREOF | WOITACH, JOSEPH T | 45d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19186177 | SHELLFISH SHUCKING KNIFE | PARSLEY, DAVID J | 78d overdue |
| 17495150 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT | SHAFQAT, AMY JEANETTE | 43d overdue |
| 18763063 | SYSTEMS AND METHODS FOR TISSUE ANALYSIS AND VISUALIZATION | CELESTINE, NYROBI I | 3d overdue |
| 19184676 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL NEUROMODULATION | GIULIANI, THOMAS ANTHONY | 12d |
| 17495144 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT | SHAFQAT, AMY JEANETTE | 12d |
| 18030346 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT | GIULIANI, THOMAS ANTHONY | 14d |
| 18763091 | SYSTEMS AND METHODS FOR EVENT-DRIVEN ULTRASOUND SAMPLING | CELESTINE, NYROBI I | 41d |
| 19232420 | DOUBLE BLIND WINE TASTING | EL-HAGE HASSAN, ABDALLAH A | — |
| Art Unit | Apps |
|---|---|
| 3794 | 5 |
| 3798 | 5 |
| 3791 | 4 |
| 1626 | 3 |
| 1677 | 2 |
| 1629 | 2 |
| 1691 | 2 |
| 1632 | 2 |
| 3775 | 2 |
| 1658 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19232420 | DOUBLE BLIND WINE TASTING | Cliink LLC | EL-HAGE HASSAN, ABDALLAH A | §101 | Non-Final OA | — | Pending | Jun 09, 2025 | |
| 19214187 | MAGNETIC CAPTURE DEVICE | Lo Biosciences, Inc. | MIANO, JOSEPH PAUL | 1631 | §103DP | Non-Final OA | — | Pending | May 21, 2025 |
| 19186177 | SHELLFISH SHUCKING KNIFE | Coastal Creative LLC | PARSLEY, DAVID J | 3643 | §103 | Final Rejection | 78d overdue | Pending | Apr 22, 2025 |
| 19184676 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL NEUROMODULATION | Neurent Medical Limited | GIULIANI, THOMAS ANTHONY | 3794 | §103§112 | Final Rejection | 12d | Pending | Apr 21, 2025 |
| 19184746 | LAND ACQUISITION AND PROPERTY DEVELOPMENT ANALYSIS PLATFORM | Landclan Limited | UBER, NATHAN C | 3626 | §101§102 | Non-Final OA | — | Pending | Apr 21, 2025 |
| 19116091 | COMBINED SENSOR DETECTION PLATFORM | Purdue Research Foundation | NGUYEN, SANG H | 2877 | §102§103 | Final Rejection | — | Pending | Mar 27, 2025 |
| 19075578 | SYSTEMS AND METHODS FOR PRINTING AND APPLYING LABELS | DMT SOLUTIONS GLOBAL CORPORATION | SELLS, JAMES D | §103 | Non-Final OA | — | Pending | Mar 10, 2025 | |
| 19066714 | SIMULTANEOUS MULTI-SITE VAGUS NERVE NEUROMODULATION FOR IMPROVED GLYCEMIC CONTROL SYSTEM AND METHODS | Reshape Lifesciences, Inc. | COLLARD JR, DWANE EDWARD | §102§103§112 | Non-Final OA | — | Pending | Feb 28, 2025 | |
| 19061441 | DEVICES AND METHODS FOR TREATING EDEMA | White Swell Medical Ltd. | ALTER MORSCHAUSER, ALYSSA MARGO | §102§103§112Other | Non-Final OA | — | Pending | Feb 24, 2025 | |
| 19051479 | SYSTEMS AND METHODS FOR DYNAMICALLY SYNCHRONIZING HAPTIC AND VISUAL SIMULATION DATA | Fvrvs Limited | CRAWFORD, JACINTA M | §103 | Non-Final OA | — | Pending | Feb 12, 2025 | |
| 19042314 | DEVICES, SYSTEMS, AND METHODS FOR PROVIDING SECURE BRANCH-FREE PASSWORD AUTHENTICATION | Tropic Square S.R.O | POTRATZ, DANIEL B | 2491 | §112 | Non-Final OA | — | Pending | Jan 31, 2025 |
| 19029407 | SINGLE-PIECE HINGED CLAMP FOR TRACK MOUNTING ASSEMBLIES | Sunrun, Inc. | MINTZ, RODNEY K | 3635 | §112Other | Non-Final OA | — | Pending | Jan 17, 2025 |
| 19021430 | LYOPHILIZED FORMULATIONS OF TEGAVIVINT | Iterion Therapeutics, Inc. | TCHERKASSKAYA, OLGA V | §101§112Other | Non-Final OA | — | Pending | Jan 15, 2025 | |
| 18877731 | NEUROMODULATION OF TWO OR MORE NEURONAL TARGETS IN TREATMENT OF A MEDICAL CONDITION | Reshape Lifesciences, Inc. | TEHRANI, DANIEL | §102§103 | Final Rejection | — | Pending | Dec 20, 2024 | |
| 18984151 | VIRTUAL REALITY SURGICAL TRAINING SYSTEMS WITH ADVANCED HAPTIC FEEDBACK | Fvrvs Limited | GRANT, MICHAEL CHRISTOPHER | §101§102DP | Non-Final OA | — | Pending | Dec 17, 2024 | |
| 18976947 | RAPID LEACHING AND DEWATERING TECHNOLOGY (RLDT) FOR EX-SITU REMEDIATION OF PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) AND OTHER CONTAMINANTS IN SOIL | Next Earth Environmental LLC, C/O Hrp Associates, Inc. | TOLEDO-DURAN, EDWIN J | 3678 | §103§112 | Non-Final OA | — | Pending | Dec 11, 2024 |
| 18972013 | TREATING CANCER WITH CAS ENDONUCLEASE COMPLEXES | Stitch Bio, LLC | MOLOYE, TITILAYO | §102§103§112 | Non-Final OA | — | Pending | Dec 06, 2024 | |
| 18964231 | AUTOMATED SKIN CLOSURE SYSTEM | Opus Ksd Inc. | IGBOKO, CHIMA U | §103 | Non-Final OA | — | Pending | Nov 29, 2024 | |
| 18958497 | MAILING OPTIMIZATION SYSTEMS AND METHODS | DMT SOLUTIONS GLOBAL CORPORATION | DULANEY, BENJAMIN O | §102§103 | Non-Final OA | — | Pending | Nov 25, 2024 | |
| 18944843 | DRUG-ELUTING SURGICAL ARTICLES AND METHODS OF USE THEREOF | Biosapien Inc. | CONIGLIO, AUDREA JUNE BUCKLEY | §103§112 | Non-Final OA | — | Pending | Nov 12, 2024 | |
| 18931823 | SYSTEMS AND METHODS FOR PROVIDING PERSONALIZED HEALTH RISK ASSESSMENTS AND RECOMMENDATIONS | Aktivolabs Pte. Ltd. | HANKS, BENJAMIN L | 3684 | §101§103 | Final Rejection | 103d overdue | Pending | Oct 30, 2024 |
| 18918921 | INTRAVASCULAR CATHETERS | White Swell Medical Ltd. | D ABREU, MICHAEL JOSEPH | §102 | Non-Final OA | — | Pending | Oct 17, 2024 | |
| 18907844 | SYSTEMS AND METHODS FOR CONDUCTING REACTIONS AND SCREENING FOR REACTION PRODUCTS | Purdue Research Foundation | WANG, JING | §112Other | Non-Final OA | — | Pending | Oct 07, 2024 | |
| 18884815 | IN VITRO ASSAY TO PREDICT CARDIOTOXICITY | Stemina Biomarker Discovery, Inc. | VOLKOV, ALEXANDER ALEXANDROVIC | 1677 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 13, 2024 |
| 18830947 | SYSTEMS AND METHODS FOR TREATING PULMONARY EDEMA | White Swell Medical Ltd. | WIEST, PHILIP R | §101§102§103 | Final Rejection | — | Pending | Sep 11, 2024 | |
| 18825146 | SYSTEMS AND METHODS FOR TREATING HEADACHE DISORDERS | Neurent Medical Limited | BOCK, ABIGAIL MARIE | 3794 | §103 | Final Rejection | — | Pending | Sep 05, 2024 |
| 18823050 | STABLE POLYMORPHIC COMPOSITIONS OF BREQUINAR SODIUM AND METHODS OF USE AND MANUFACTURE THEREOF | Clear Creek Bio, Inc. | SHOWALTER, ALEXANDER KEITH | §103§112DP | Non-Final OA | — | Pending | Sep 03, 2024 | |
| 18816456 | DEVICE FOR THERAPEUTIC SINO-NASAL TREATMENT | Neurent Medical Limited | LEE, DAVINA EN-YIN | 3794 | §102§112 | Non-Final OA | — | Pending | Aug 27, 2024 |
| 18812194 | SECURING MEDICAL TUBING | Alera Medtech Inc. | OSINSKI, BRADLEY JAMES | §102§103§112 | Non-Final OA | — | Pending | Aug 22, 2024 | |
| 18804859 | FORMULATIONS OF DIHYDROKAEMPFEROL | Debut Biotechnology, Inc. | CHI, AMANDA LYNN | §102§103§112 | Non-Final OA | — | Pending | Aug 14, 2024 | |
| 18798181 | SYSTEMS AND METHODS FOR TRIAGING HIGH RISK MESSAGES | Crisis Text Line, Inc. | STARKS, WILBERT L | 2122 | §101 | Final Rejection | — | Pending | Aug 08, 2024 |
| 18786006 | STABLE ANHYDROUS DISINFECTANT CONCENTRATE FORMULATION AND METHOD OF MAKING THE SAME | One Home Brands, Inc. | ALAWADI, SARAH | §103 | Non-Final OA | — | Pending | Jul 26, 2024 | |
| 18833637 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | Purdue Research Foundation | BURKE, MATTHEW RYAN | 1619 | §103 | Non-Final OA | — | Pending | Jul 26, 2024 |
| 18783819 | METHODS OF SYNTHESIZING 2-[4-[(2,3,4-TRIMETHOXYPHENYL)METHYL] PIPERAZIN-1-YL]ETHYL PYRIDINE-3-CARBOXYLATE | Imbria Pharmaceuticals, Inc. | BRAM, STANLEY | §102§103§112DP | Non-Final OA | — | Pending | Jul 25, 2024 | |
| 18780727 | METHODS OF TREATING HEART FAILURE WITH HIBERNATING MYOCARDIUM USING MODIFIED FORMS OF TRIMETAZIDINE | Imbria Pharmaceuticals, Inc. | TRAN, ERIC | 1629 | Other | Non-Final OA | — | Pending | Jul 23, 2024 |
| 18778234 | RNA TARGET ENRICHMENT OR DEPLETION OF BIOLOGICAL SAMPLES | Altratech Limited | RILEY, JEZIA | §101§103§112Other | Non-Final OA | — | Pending | Jul 19, 2024 | |
| 18763044 | SYSTEMS AND METHODS FOR ROTATIONAL ULTRASOUND FOCUSING | Luma Vision Limited | CELESTINE, NYROBI I | 3798 | §103 | Final Rejection | — | Pending | Jul 03, 2024 |
| 18763063 | SYSTEMS AND METHODS FOR TISSUE ANALYSIS AND VISUALIZATION | Luma Vision Limited | CELESTINE, NYROBI I | 3798 | §103 | Final Rejection | 3d overdue | Pending | Jul 03, 2024 |
| 18763091 | SYSTEMS AND METHODS FOR EVENT-DRIVEN ULTRASOUND SAMPLING | Luma Vision Limited | CELESTINE, NYROBI I | 3798 | §102§103 | Non-Final OA | 41d | Pending | Jul 03, 2024 |
| 18724423 | METHODS FOR REDUCING NITROUS OXIDE PRODUCTION | Agresearch Limited | KRUSE, DAVID H | 1663 | §102§112DP | Final Rejection | — | Pending | Jun 26, 2024 |
| 18722956 | AUTOMATED ULTRASOUND IMAGING ANALYSIS AND FEEDBACK | Geonomy, Ltd. | RUDOLPH, VINCENT M | 2671 | §103 | Final Rejection | — | Pending | Jun 21, 2024 |
| 18746622 | DETECTING AN ANALYTE IN A MEDIUM | Orb Xyz, Inc. | GUNBERG, EDWIN C | 2884 | §102§103 | Non-Final OA | 35d | Pending | Jun 18, 2024 |
| 18678100 | DEEP LEARNING DRIVEN ADAPTIVE OPTICS FOR SINGLE MOLECULE LOCALIZATION MICROSCOPY | Purdue Research Foundation | VARNDELL, ROSS E | 2674 | §103§112 | Final Rejection | — | Pending | May 30, 2024 |
| 18667133 | BIN OUTPUT EXPANDER DEVICES, SYSTEMS, AND METHODS | DMT SOLUTIONS GLOBAL CORPORATION | DEVINE, MOLLY K | 3653 | §102§103 | Final Rejection | 86d overdue | Pending | May 17, 2024 |
| 18647109 | METHODS FOR CHARACTERIZING LOW-ABUNDANCE HOST CELL PROTEINS | Regeneron Pharmaceuticals, Inc. | CHIN, CHRISTOPHER L | 1677 | §101 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18638472 | CANNABIDIOLIC ACID COCRYSTALS | Manoira Corporation | BRADY, KRISTEN WEEKS | §102§103§112DP | Non-Final OA | — | Pending | Apr 17, 2024 | |
| 18624508 | METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION FRACTION USING MODIFIED FORMS OF TRIMETAZIDINE | Imbria Pharmaceuticals, Inc. | SHIAO, REI TSANG | 1691 | DP | Non-Final OA | — | Pending | Apr 02, 2024 |
| 18605038 | DATA COMMUNICATIONS SYSTEMS AND METHODS | Glo-Cap LLC | WYLLIE, CHRISTOPHER T | 2465 | §102§103 | Non-Final OA | 30d | Pending | Mar 14, 2024 |
| 18692014 | VIRUS COMPOSITIONS TO EFFICIENTLY TARGET THE NERVOUS SYSTEM AND THE LUNGS | Capsida Biotherapeutics, Inc. | BOESEN, AGNIESZKA | 1632 | §112 | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18685109 | PEPTIDE-HLA-B*35 Libraries, Associated Compositions, and Associated Methods of Use | 3T Biosciences, Inc. | RAYMONDA, MATTHEW HAROLD | §102§103§112DP | Non-Final OA | — | Pending | Feb 20, 2024 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial83.3% of resolved applications prosecuted by Brown Rudnick, LLP were allowed, across 4,189 applications in USPTO records.
3.89 office actions per allowed application on average.
111 pending office actions as of October 2026, for 61 clients, before 107 examiners in 62 art units.